Irbesartan contraindications

Revision as of 16:17, 20 February 2014 by ShiSheng (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Irbesartan
AVAPRO® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Irbesartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

AVAPRO is contraindicated in patients who are hypersensitive to any component of this product.

Do not coadminister aliskiren with AVAPRO in patients with diabetes (see PRECAUTIONS: Drug Interactions).[1]

References

  1. "AVAPRO (IRBESARTAN) TABLET [SANOFI-AVENTIS U.S. LLC]". Retrieved 20 February 2014.

Template:Angiotensin II receptor antagonists